-
Paz-Bailey G, Adams LE, Deen J, Anderson KB, Katzelnick LC. Dengue. Lancet. 2024;403(10427):667-82. WHO Guidelines
-
Approved by the Guidelines Review Committee. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition. WHO Guidelines Approved by the Guidelines Review Committee. Geneva: World Health Organization WHO; 2009.
-
Situation Report No 8 - Dengue Epidemiological Situation in the Region of the Americas - Epidemiological 2024 march 6 2024. Available from:
https://www.paho.org/en/documents/situation-report-no-8-dengue-epidemiological-situation-region-americas-epidemiological.
-
Report of the epidemiological situation of dengue in Colombia - Epidemiological Period XIII 2023: National Institute of Health Colombia (INS); 2023 [Available from:
https://www.ins.gov.co/buscador-eventos/_layouts/15/DocIdRedir.aspx?ID=AVMXRNAJRR5T-1334852614-5406.
-
Velandia-Romero ML, Coronel-Ruiz C, Castro-Bonilla L, Camacho-Ortega S, Calderon-Pelaez MA, Castellanos A, et al. Prevalence of dengue antibodies in healthy children and adults in different Colombian endemic areas. Int J Infect Dis. 2020;91:9-16.
-
Barry MR, Villar LA, Herran OF, Lozano-Parra A, Estupinan MI, Herrera VM, Villamor E. Seropositivity and history of hospitalization for dengue in relation to anthropometric indices among Colombian children and adults. Epidemiol Infect. 2021;149:e58.
-
Tomashek KM, Lorenzi OD, Andujar-Perez DA, Torres-Velasquez BC, Hunsperger EA, Munoz-Jordan JL, et al. Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015. PLoS Negl Trop Dis. 2017;11(9):e0005859.
-
Sangkaew S, Ming D, Boonyasiri A, Honeyford K, Kalayanarooj S, Yacoub S, et al. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(7):1014-26.
-
Shafie AA, Moreira ED, Jr., Di Pasquale A, Demuth D, Yin JYS. Knowledge, Attitudes and Practices toward Dengue Fever, Vector Control, and Vaccine Acceptance Among the General Population in from Latin America and Asia Pacific: A Cross-Sectional Study (GEMKAP). Vaccines (Basel). 2023;11(3).
